CAPLIPOINT — Caplin Point Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹174.93bn
- IN₹164.61bn
- IN₹21.87bn
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees
Brief: Caplin Point Laboratories Unit Receives USFDA Approval For Methylprednisolone Acetate
Brief: Caplin Point Laboratories Completion Of Inspection By Invima-Colombia At The Puducherry Injectables Facility
Brief: Caplin Point Laboratories Unit Gets USFDA Final Approval For Linezolid Injection, Infusion Bags
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For Its ANDA Acetaminophen Injection
Brief: Caplin Point Laboratories Appoints Ashok Partheeban As Vice-Chairman
Brief: Caplin Point Laboratories Sept-Quarter Consol Net Profit 1.54 Billion Rupees
Brief: Caplin Point Laboratories Says Caplin Steriles Receives USFDA Approval For Nicardipine Injection
Brief: Caplin Point Laboratories March-Qtr Consol Net Profit 1.43 Bln Rupees
Brief: Caplin Point Laboratories Unit Approves Investment In Neoethicals Chile SpA
Brief: Caplin Point Laboratories Gets USFDA Approval For Brimonidine Tartrate, Timolol Maleate
India's Caplin Point gains on unit getting US FDA nod for generic heart disorder drug
Brief: Caplin Point Laboratories Says Unit Gets USFDA Approval For Procainamide Hydrochloride Injection
India's Caplin Point rises on no observations in US FDA inspection
Brief: Caplin Point Laboratories Receives EIR From FDA For Gummidipoondi Facility
Brief: Caplin Point Laboratories Says Caplin Steriles Gets USFDA Approval For Difluprednate Ophthalmic Emulsion